CN1899478A - Chinese medicine composition for treating malignant tumor - Google Patents
Chinese medicine composition for treating malignant tumor Download PDFInfo
- Publication number
- CN1899478A CN1899478A CN 200610084934 CN200610084934A CN1899478A CN 1899478 A CN1899478 A CN 1899478A CN 200610084934 CN200610084934 CN 200610084934 CN 200610084934 A CN200610084934 A CN 200610084934A CN 1899478 A CN1899478 A CN 1899478A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- malignant tumor
- cancer
- treating malignant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine composition for treating malignant tumor is prepared with nutagrass flatsedge rhizome 95-98 wt%, giant knotweed 1-3 wt% and seaweed 1-3 wt%, and may be prepared into injection, orally taken medicine powder or bolus. It has obvious anticancer activity, capacity of raising body's immunity, powerful cancer cell killing and inhibiting effect, no toxic side effect, and ability of strengthening chemotherapy function and lowering chemotherapy toxic side effect. It is used clinically in treating esophagus cancer, lung cancer, gastric cancer, etc.
Description
Technical field
The invention discloses a kind of Chinese medicine composition, particularly treating malignant tumor is the Chinese medicine composition of cancer.
Background technology
Malignant tumor is that cancer is one of disease of serious harm health of people and life.According to statistics, China annual New Development cancer patient 1,600,000 people, sickness rate is up to 1,39/,100,000.The patient who dies from cancer every year is 1,300,000 people.Therefore constantly seek and open up the medical skill of treatment of cancer, become an important topic.Administer opinion dialectical the executing of utilization Chinese medicine at present; utilize Chinese medicine malignant tumor aspect; prior art is: by adopting the kinds of traditional Chinese medicines composite formula; make oral agents or injection; clinically be used for patient, patient's autoimmunity is enhanced, the normal function of human body is recovered; cancerous cell is suppressed and is killed, and reaches therapeutic purposes.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of malignant tumor, this Chinese medicine composition is made up of the Chinese medicine of less flavor, by the strengthening vital QI to eliminate pathogenic factors effect to function of human body, realizes the purpose of treatment malignant tumor.
Technical scheme of the present invention is as follows: this Chinese medicine composition is made up of Rhizoma Cyperi, Rhizoma Polygoni Cuspidati, Sargassum three flavor Chinese medicines, and the percentage ratio that each raw material of Chinese medicine of distinguishing the flavor of accounts for composition total weight is: Rhizoma Cyperi 95%-98%, Rhizoma Polygoni Cuspidati 1%-3%, Sargassum 1%-3%.In this compositions, Rhizoma Cyperi, suffering, little hardship, sweet, flat, go into liver, stomach, spleen channel, the tool promoting flow of QI and blood, anticancer function relieves internal heat; Rhizoma Polygoni Cuspidati, hardship, flat, go into liver, stomach, gallbladder meridian, tool promoting blood circulation and breaking stagnation knot, the pain that relieves the pain effect; Sargassum, hardship, salty, cold, go into lung, stomach warp, tool expectorant row water, hard masses softening and resolving effect.Above-mentioned three flavor drug matchings, but circulation of qi promoting, promoting the circulation of blood, logical strongly fragrant, expectorant removes the stasis of blood, the pain of delaying, relieve the pain, detumescence removes tumor.
Test through general pharmacology, acute toxicity test, long term toxicity test, anaphylaxis, hemolytic, irritation test, anti-tumor experiment, modern medicine methods such as attenuation synergistic test to chemotherapy prove, Chinese medicine composition medicine of the present invention has tangible active anticancer, can improve patient's body immunity comprehensively, cancer cell is had stronger killing and the inhibition ability, human body is had no side effect, and can strengthen the chemotherapy effect, reduce chemical therapy toxic side effect, the clinical esophageal carcinoma that is used for the treatment of, pulmonary carcinoma, gastric cancer, intestinal cancer, thyroid carcinoma, uterus carcinoma, breast carcinoma, cerebroma, bladder cancer, lymphatic cancers etc. have tangible curative effect.
The specific embodiment
Use this Chinese medicine composition, make injection (universe injection) by the Chinese medicine extraction technology.Get Rhizoma Cyperi 96%, Rhizoma Polygoni Cuspidati 2%, the weight combinations of Sargassum 2% is a raw material, adds the water distilling under reduced pressure, collect distillate and medicinal residues and squeeze the juice, the distillate redistillation, the cold preservation of collection distillate is standby.Medicinal residues add the water water proof and decoct twice, and collecting decoction filters, concentrates, and adds ethanol, the cold preservation after-filtration, filtrate recycling ethanol, reconcentration is put and is added ethanol after cold, mocromembrane filters after the cold preservation, filtrate recycling ethanol, and reconcentration adds ethanol, mocromembrane filters after the cold preservation, and filtrate is recycled to no ethanol flavor, adds distillate, sodium chloride, tween 80, water for injection, adjust pH value, mocromembrane filters back bottling, high temperature sterilize, the cold preservation after-filtration, the fill ampoule, the per ampoule dose is in contained Chinese medicine composition crude drug amount.Dissolve in when using this injection for treating in Glucose Liquid or the normal saline, carry out intravenous injection or intramuscular injection, by used Chinese medicine composition crude drug amount, divide large, medium and small three kinds of dosages, that is: 20g/Kg, 10g/Kg, 5g/Kg, 30 days is a course of treatment.Use through clinical treatment, the therapeutic effect statistics is as follows.
64 routine tumor patient therapeutic effect statistical tables (accept more than 10 days therapist be radix)
| Case | Age | Therapeutic effect | |||||||
| 30-49 year | 50-59 year | More than 60 years old | Effective number | The healing number | Invalid number | ||||
| The man | The woman | The man | The woman | The man | The woman | ||||
| Esophageal carcinoma | 2 | 0 | 3 | 1 | 1 | 0 | 4 | 2 | 1 |
| Pulmonary carcinoma | 1 | 1 | 3 | 0 | 2 | 0 | 2 | 4 | 1 |
| Gastric cancer | 2 | 0 | 5 | 0 | 2 | 1 | 3 | 7 | 0 |
| Intestinal cancer | 0 | 2 | 2 | 1 | 1 | 1 | 2 | 5 | 0 |
| Thyroid carcinoma | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 |
| Uterus carcinoma | 0 | 6 | 0 | 0 | 0 | 2 | 2 | 6 | 0 |
| Breast carcinoma | 0 | 3 | 0 | 4 | 0 | 0 | 1 | 6 | 0 |
| Cerebroma | 2 | 1 | 1 | 0 | 0 | 0 | 3 | 1 | 0 |
| Bladder cancer | 0 | 1 | 2 | 1 | 3 | 0 | 4 | 3 | 0 |
| Lymphatic cancer | 0 | 1 | 2 | 1 | 0 | 0 | 1 | 3 | 0 |
| Add up to | 23 | 28 | 15 | 22 | 40 | 2 | |||
According to above statistics, the treatment effective percentage is 34.4%, and cure rate is 62.5%, and inefficiency is 3.1%, and total effective rate was 96.9% (above-mentioned effective percentage adds cure rate).
Chinese medicine composition of the present invention is made common process according to Chinese medicine, also can be made as to be used for oral powder or pill.
Claims (3)
1. Chinese medicine composition for the treatment of malignant tumor is characterized in that: be by Rhizoma Cyperi, and Rhizoma Polygoni Cuspidati, Sargassum is formed, and its weight consists of: Rhizoma Cyperi 95%-98%, Rhizoma Polygoni Cuspidati 1%-3%, Sargassum 1%-3%.
2. the Chinese medicine composition of treatment malignant tumor according to claim 1 is characterized in that: its weight consists of Rhizoma Cyperi 96%, Rhizoma Polygoni Cuspidati 2%, Sargassum 2%.
3. the Chinese medicine composition of treatment malignant tumor according to claim 1 and 2 is characterized in that: be made as injection by said composition, or be used for oral powder or pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610084934 CN1899478A (en) | 2006-06-02 | 2006-06-02 | Chinese medicine composition for treating malignant tumor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610084934 CN1899478A (en) | 2006-06-02 | 2006-06-02 | Chinese medicine composition for treating malignant tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1899478A true CN1899478A (en) | 2007-01-24 |
Family
ID=37655589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610084934 Pending CN1899478A (en) | 2006-06-02 | 2006-06-02 | Chinese medicine composition for treating malignant tumor |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1899478A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751468A (en) * | 2014-01-02 | 2014-04-30 | 王东克 | Traditional Chinese medicine for treating cancers |
| CN105920454A (en) * | 2016-06-24 | 2016-09-07 | 贵州盛世保康茶开发有限公司 | Capsule for removing blood stasis and tumor |
-
2006
- 2006-06-02 CN CN 200610084934 patent/CN1899478A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751468A (en) * | 2014-01-02 | 2014-04-30 | 王东克 | Traditional Chinese medicine for treating cancers |
| CN105920454A (en) * | 2016-06-24 | 2016-09-07 | 贵州盛世保康茶开发有限公司 | Capsule for removing blood stasis and tumor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301400B (en) | A kind of Chinese medicine composition and preparation method for the treatment of chronic atrophic gastritis | |
| CN104857092A (en) | Traditional Chinese medicine suppository for treating constipation | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN105535495A (en) | Chinese medicinal composition for treating esophageal cancer by reinforcing vital essence and strengthening primordial qi and preparation method | |
| CN1899478A (en) | Chinese medicine composition for treating malignant tumor | |
| CN102872362B (en) | Traditional Chinese medicine for treating chronic cholecystitis | |
| CN114796325A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method and application thereof | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN104147261B (en) | A kind of Chinese medicine preparation for treating rheumatic arthritis | |
| CN107753921B (en) | Traditional Chinese medicine navel plaster for treating hyperemesis gravidarum | |
| CN101983682A (en) | Medicament for treating female climacteric metancholia | |
| CN104258247A (en) | Traditional Chinese medicine preparation for treating pleural effusion | |
| CN102488832B (en) | Traditional Chinese medicine composition for treating mastitis | |
| CN101791372A (en) | Chinese medicine for treating radiation pharyngitis | |
| CN104587085A (en) | Application of saffron traditional Chinese medicine composition to prepare medicaments treating rhinitis | |
| CN104815092A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN104491060A (en) | Tradtional Chinese medicine for preventing relapse of glioma | |
| CN102688400A (en) | Succus bambusae traditional Chinese medicine oral liquid for treating cough and preparation method for oral liquid | |
| CN103520638B (en) | A kind of Traditional Chinese medicine compound composition for the treatment of prostate hyperplasia and preparation method thereof and application thereof | |
| CN1935224A (en) | Chinese medicine for treating malignant tumour | |
| CN105726849B (en) | It is a kind of for treating the Chinese medicine of diabetes Depression | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN104800693B (en) | A kind of Chinese medicine composition for treating lung cancer | |
| CN104147173A (en) | Chinese medicinal composition for treating acute alcoholism |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |